Baylor College of Medicine
Houston, Texas, 77030, United States
NCT Number: NCT00749840
Through a prospective observational cohort study enrolling patients newly diagnosed with Human immunodeficiency virus (HIV):
Aim 1: Assess attitudes and beliefs about HIV disease and care over time and relate those attitudes and beliefs to success in following the Steps of HIV Care.
Aim 2: Validate a simple visual analogue scale for assessing adherence to highly active antiretroviral therapy (HAART) in patients newly starting HAART in routine care.
Aim 3: Implement latent growth curve analysis for modeling changes in attitudes and beliefs over time, and for assessing the impact of the components of the Steps of HIV Care model on health outcomes.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Houston, Texas, 77030, United States
The introduction of highly active antiretroviral therapy (HAART) dramatically improved the survival of patients with HIV in the US. The effectiveness of HAART in routine care is determined by the success with which patients are able to follow certain crucial Steps of HIV Care. This 'Steps of HIV Care' framework is based on the Centers for Disease Control and Prevention's (CDC's) "Serostatus Approach to Fighting the HIV Epidemic," which has been overlaid with patient and process of care factors. It includes 1) access outpatient care, 2) utilize care and treatment services, and 3) adhere to care, including medications and appointments.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Questionnaire taking 60-90 minutes.
Other names: Survey
Time frame: Interviewer-administered at time of enrollment and every 3 months for 18 months
M.D. Anderson Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02452242
Human Immunodeficiency Virus Infections
Curepipe, Mauritius
View Trial DetailsNCT00294164
Human Immunodeficiency Virus Infections, Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)
View Trial DetailsNCT00294918
Human Immunodeficiency Virus Infections, Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)
View Trial DetailsNCT00727597
Human Immunodeficiency Virus Infections
Washington D.C., District of Columbia, United States
View Trial Details